How do you treat high-risk stage II colon cancer patients? Nothing vs. FP vs. doublet including MSI high patients

Date 30 September 2019
Event ESMO 2019 Congress
Session Adjuvant treatment duration for high-risk stage II colon cancer
Topics Colon and Rectal Cancer
Presenter Claus-Henning Koehne
Authors C. Koehne
  • Universitätsklinik Onkologie / Hämatologie, Klinikum Oldenburg, 26133 - Oldenburg/DE